Risk factors for and prevention of human papillomaviruses (HPV), genital warts and cervical cancer

C Chelimo, TA Wouldes, LD Cameron, JM Elwood - Journal of Infection, 2013 - Elsevier
Genital HPV infection is associated with development of cervical cancer, cervical neoplasia,
anogenital warts, and other anogenital cancers. A number of reviews have primarily …

Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease

CJN Lacey, CM Lowndes, KV Shah - Vaccine, 2006 - Elsevier
Human Papillomavirus (HPV)-6 and-11 are the causative agents of ano-genital warts (GWs)
and recurrent respiratory papillomatosis (RRP). They are low-risk HPV types that are …

Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data

EA Joura, SM Garland, J Paavonen, DG Ferris, G Perez… - Bmj, 2012 - bmj.com
Objectives To determine the effect of human papillomavirus (HPV) quadrivalent vaccine on
the risk of developing subsequent disease after an excisional procedure for cervical …

[HTML][HTML] Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and …

Future I/II Study Group - The BMJ, 2010 - ncbi.nlm.nih.gov
Objectives To evaluate the prophylactic efficacy of the human papillomavirus (HPV)
quadrivalent vaccine in preventing low grade cervical, vulvar, and vaginal intraepithelial …

Economic evaluation of human papillomavirus vaccination in the United Kingdom

M Jit, YH Choi, WJ Edmunds - Bmj, 2008 - bmj.com
Objective To assess the cost effectiveness of routine vaccination of 12 year old schoolgirls
against human papillomavirus infection in the United Kingdom. Design Economic …

Estimation of the impact of genital warts on health-related quality of life

S Woodhall, T Ramsey, C Cai, S Crouch, M Jit… - Sexually transmitted …, 2008 - sti.bmj.com
Objectives: One of the two new human papillomavirus (HPV) vaccines protects against HPV
types 6 and 11, which cause over 95% of genital warts, in addition to protecting against HPV …

The impact of genital warts: loss of quality of life and cost of treatment in eight sexual health clinics in the UK

SC Woodhall, M Jit, K Soldan, G Kinghorn… - Sexually transmitted …, 2011 - sti.bmj.com
Objectives To estimate the loss of quality of life and cost of treatment associated with genital
warts seen in sexual health clinics. Methods A cross-sectional questionnaire study and case …

[HTML][HTML] Clinical effectiveness and cost-effectiveness of interventions for the treatment of anogenital warts: systematic review and economic evaluation.

E Thurgar, S Barton, C Karner… - Health Technology …, 2016 - ncbi.nlm.nih.gov
BACKGROUND Typically occurring on the external genitalia, anogenital warts (AGWs) are
benign epithelial skin lesions caused by human papillomavirus infection. AGWs are usually …

Epidemiology and cost of treatment of genital warts in Spain

X Castellsagué, C Cohet… - … European Journal of …, 2009 - academic.oup.com
Background: Genital warts (GW) are common and increasing in young people. Ninety
percent of GW are due to Human Papillomavirus (HPV) types 6 and 11. The objective of this …

Costs of detection and treatment of cervical cancer, cervical dysplasia and genital warts in the UK

RE Brown, JG Breugelmans… - … medical research and …, 2006 - Taylor & Francis
ABSTRACT Objective: Infection with human Papillomavirus (HPV) is a necessary cause of
cervical cancer (CC) and genital warts (GW). HPV vaccination studies have shown excellent …